April 30, 2024
BALTIMORE — Ice packs or topical anesthesia applied to the face before thermomechanical fractional injury therapy to treat wrinkles around the eyes provided satisfactory comfort to […]
April 30, 2024
On April 29, 2024, The US Food and Drug Administration (FDA) has accepted a Supplemental New Drug Application for tapinarof cream, 1%, for the topical treatment […]
April 29, 2024
TOPLINE: Most children and adolescents with chronic skin disorders may experience stigma, which is strongly associated with reduced quality of life (QOL) and childhood depression. METHODOLOGY: […]
April 26, 2024
TOPLINE: A large international cohort study identified a higher risk for cardiovascular diseases and mortality in patients with prurigo nodularis (PN), particularly among women and White […]
April 25, 2024
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the Biologics License Application (BLA) for prademagene zamikeracel (pz-cel), which is […]
April 24, 2024
In a small, nonrandomized controlled trial, the injectable calcitonin gene-related peptide (CGRP) inhibitor erenumab significantly reduced treatment-resistant flushing and erythema associated with rosacea. Skin-related quality-of-life (QOL) […]
April 22, 2024
SAN DIEGO — Compared with the use of topical minoxidil for hair loss, the used of low-dose oral minoxidil (LDOM) can be considered when topical minoxidil […]
April 22, 2024
SAN DIEGO — In the next few years, expect intradermal injections of botulinum toxin A for the improvement in the appearance of pores, sebum, skin texture, […]
April 22, 2024
BALTIMORE — A 2910-nm erbium-doped fluoride glass fiber laser, approved 2 years ago by the US Food and Drug Administration, has demonstrated a high degree of […]